Shiraz E-Medical Journal
Imatinib is a tyrosine kinase inhibitor (TKI) which targets BCR-ABL protein in patients with chronic myelogenous leukemia (CML) and c-kit in patients with gastrointestinal stromal tu-mors (GISTs). Skin hypopigmentation is reported during Imatinib therapy. We present a case of CML who developed skin hyperpigmentation in the face during treatment with Imatinib which found chloasma-like appearance.
© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Maden S. Bilateral Symmetrical Oval Hyperpigmentation on the Face: A Case of Seborrheic Melanosis. J Skin Stem Cell. 2023;10(1):e135821. doi: https://doi.org/10.5812/jssc-135821
Dehghani M. Leukemia Cutis (Answer to the Clinical Quiz of the Previous Issue). Shiraz E-Med J. 2009;10(2):. doi:
Porto DA, C LoPiccolo M, J Kouba D. Impetigo After Actinic Keratosis Treatment With Ingenol Mebutate Gel: An Important Complication. J Skin Stem Cell. 2015;2(3):e33472. doi: https://doi.org/10.17795/jssc33472
Chavan RB, Belgaumkar VA, Deshmukh NS, Warke NV. Acral Lentiginous Melanoma on the Palm: Unusual Site with a Fatal Outcome. J Skin Stem Cell. 2019;6(3):e101299. doi: https://doi.org/10.5812/jssc.101299
Federico A, Sgambato D, Cotticelli G, Gravina AG, Dallio M, et al. Skin Adverse Events During Dual and Triple Therapy for HCV-Related Cirrhosis. Hepat Mon. 2014;14(3):e16632. doi: https://doi.org/10.5812/hepatmon.16632
Last Update: 3 weeks ago
Last Update: 3 weeks ago
Last Update: 3 weeks ago
Last Update: 5 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
